Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc logo

BCRX - BioCryst Pharmaceuticals Inc Reuters News

$11.15 0.2  2.1%

Last Trade - 05/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Momentum Trap
Market Cap £1.43bn
Enterprise Value £1.41bn
Revenue £12.9m
Position in Universe 2176th / 6651
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BCRX Dividends
Reuters News
All News Reuters News Company Announcements
BRIEF-BioCryst Submits Marketing Authorization Application For UK Approval Of Orladeyo
Tue 12:25pm News
BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
Tue 12:00pm News
BRIEF-Biocryst Pharmaceuticals Files For Potential Mixed Shelf Offering Size Not Disclosed
Mon 10:34pm News
U.S. RESEARCH ROUNDUP- Editas Medicine, HP, LivePerson
26th Feb News
BRIEF-Biocryst - Receives Positive CHMP Opinion For Orladeyo An Oral, Once-Daily Therapy To Prevent Attacks In Patients With Hereditary Angioedema
25th Feb News
BioCryst Receives Positive CHMP Opinion for ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
25th Feb News
BUZZ-BioCryst: Tumbles after grim quarterly results
25th Feb News
BRIEF-BioCryst Reports Q4 Loss Per Share Of $0.34
25th Feb News
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones
25th Feb News
BioCryst to Present at Upcoming Investor Conferences
18th Feb News
BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
11th Feb News
BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting
9th Feb News
BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older
3rd Feb News
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2nd Feb News
BUZZ-Biocryst rises after mention on Reddit's WallStreetBets forum
1st Feb News
BUZZ-U.S. STOCKS ON THE MOVE-SVB Financial, Montauk Renewables, IBM, Aurora Cannabis, Broadwind
22nd Jan News
BUZZ-U.S. STOCKS ON THE MOVE-AMC, Corsair Gaming, IBM, Aurora Cannabis, Broadwind
22nd Jan News
BUZZ-BioCryst: Rises as Japan approves co's genetic disorder drug
22nd Jan News
BRIEF-Biocryst Announces Approval Of Orladeyo™ (Berotralstat) In Japan For The Prophylactic Treatment Of Hereditary Angioedema
22nd Jan News
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
22nd Jan News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.